2019
DOI: 10.1097/tp.0000000000002461
|View full text |Cite
|
Sign up to set email alerts
|

Effect of the Selective NLRP3 Inflammasome Inhibitor mcc950 on Transplantation Outcome in a Pig Liver Transplantation Model With Organs From Donors After Circulatory Death Preserved by Hypothermic Machine Perfusion

Abstract: Background We investigated whether the outcome of organs from donors after circulatory death (DCD) can be improved by the addition of mcc950 to the perfusate of the hypothermic machine perfusion (HMP) system and intravenous mcc950 injection after transplantation in a pig liver transplantation model. Methods Thirty-six healthy Bama mini pigs randomized into 3 groups. All the DCD livers were preserved in an HMP system after 2 hours of simple cold storage.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(26 citation statements)
references
References 36 publications
1
19
0
Order By: Relevance
“…Organs were submitted to 30 min of warm ischemia, 2 h of cold ischemia and preserved in a hypothermic machine perfusion system for 2 h before the implantation of liver grafts in the recipient. Mcc950, a novel NLRP3-inflammasome selective small-molecule inhibitor, was added to the perfusate of the hypothermic machine perfusion and administered to recipients [155]. The study shows that the addition of Mcc950 improved the outcomes of LT from DCD donors via inhibition of the inflammatory response, reduction of hepatocyte apoptosis, and improvement of liver function (Figure 3) [155].…”
Section: Relevance Of Inflammasome In Hepatic Ischemia-reperfusionmentioning
confidence: 99%
See 1 more Smart Citation
“…Organs were submitted to 30 min of warm ischemia, 2 h of cold ischemia and preserved in a hypothermic machine perfusion system for 2 h before the implantation of liver grafts in the recipient. Mcc950, a novel NLRP3-inflammasome selective small-molecule inhibitor, was added to the perfusate of the hypothermic machine perfusion and administered to recipients [155]. The study shows that the addition of Mcc950 improved the outcomes of LT from DCD donors via inhibition of the inflammatory response, reduction of hepatocyte apoptosis, and improvement of liver function (Figure 3) [155].…”
Section: Relevance Of Inflammasome In Hepatic Ischemia-reperfusionmentioning
confidence: 99%
“…Mcc950, a novel NLRP3-inflammasome selective small-molecule inhibitor, was added to the perfusate of the hypothermic machine perfusion and administered to recipients [155]. The study shows that the addition of Mcc950 improved the outcomes of LT from DCD donors via inhibition of the inflammatory response, reduction of hepatocyte apoptosis, and improvement of liver function (Figure 3) [155]. In the context of clinical practice, the encouraging results of this experiment in regulating NLRP3 activity in DCD donations with short ischemic periods, urges increased efforts to minimize both warm ischemia and cold ischemia times during DCD organ procurement and transplantation in order to improve the viability of liver grafts and recipients after LT [156,157].…”
Section: Relevance Of Inflammasome In Hepatic Ischemia-reperfusionmentioning
confidence: 99%
“…In mice with hypertension, MCC950 reduced blood pressure and limited renal inflammation, fibrosis, and dysfunction (Krishnan et al, 2019). In a porcine liver transplantation model, MCC950 improved the prognosis of organs from donors after circulatory death (Yu, Cheng, et al, 2019). In ischaemia/reperfusion-induced lung injury, reduced the production of IL-1b and IL-18 and inhibited neutrophil infiltration and apoptosis (Xu, Wu, et al, 2018).…”
Section: Inhibitors Of the Activation Stepmentioning
confidence: 99%
“…The width (A), the length (B) and the angle (C) of collagen fibers within the tunica media were assessed using the CT-FIRE software as described previously. 1 with saponin (open square). AB reduction was determined as AB reduction = FI(Sample)590 -FI(Ctrl)590 / FI(Ctrl+)590-FI(Ctrl-)590.…”
Section: Supplemental Legendsmentioning
confidence: 99%